Gene transfer of virally encoded chemokine antagonists vMIP-II and MC148 prolongs cardiac allograft survival and inhibits donor-specific immunity

Gene Therapy

Volumn 7, Issue 7, 2000, Pages 575-582

  DeBruyne, L A ^a   Li, K ^a   Bishop, D K ^a   Bromberg, J S ^a,b,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Gene therapy transplantation; Human herpes virus 8; Molluscum contagiosum; T cells

Indexed keywords

ALLOANTIBODY; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR ANTAGONIST; IMMUNOMODULATING AGENT; INTERLEUKIN 10; MC 148; PLASMID DNA; UNCLASSIFIED DRUG; VMIP II;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE TRANSFER; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN HERPESVIRUS 8; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; MOLLUSCUM CONTAGIOSUM; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; HERPES; HERPES VIRUS 8; HERPESVIRIDAE; HERPESVIRUS 8; HUMAN HERPES VIRUS; HUMAN HERPES VIRUS 8; HUMAN HERPESVIRUS 8; MOLLUSCUM CONTAGIOSUM;

EID: 0034066276     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301128     Document Type: Article

References (46)

1. Luster AD. Chemokines - chemotatic cytokines that mediate inflammation. New Engl J Med 1998; 338: 436-445.
2. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997; 15: 675-705.
3. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392: 565-568.
4. Premack BA, Schall TJ. Chemokine receptors: gateways to inflammation and infection. Nature Med 1996; 2: 1174-1178.
5. Kelner GS et al. Lymphotactin: a cytokine that represents a new class of chemokine. Science 1994; 266: 1395-1399.
6. 3C motif. Nature 1997; 385: 640-644.
7. Zhong W, Wang H, Herndier B, Ganem D. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci USA 1996; 93: 6641-6646.
8. Weiss RA. Human herpesvirus 8 in lymphoma and Kaposi's sarcoma: now the virus can be propagated. Nature Med 1996; 2: 277-278.
9. Boshoff C et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nature Med 1995; 1: 1274-1278.
10. Boshoff C et al. Kaposi's-sarcoma-associated herpesvirus in HIV negative Kaposi's sarcoma. Lancet 1995; 345: 1043-1044.
11. Dupin N et al. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 1995; 345: 761-762.
12. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. New Engl J Med 1995; 332: 1181-1185.
13. Chang Y et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-1896.
14. Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996; 274: 1739-1744.
15. Nicholas J et al. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nature Med 1997; 3: 287-292.
16. Kledal TN et al. A broad spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science 1997; 277: 1656-1659.
17. Boshoff C et al. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 1997; 278: 290-294.
18. Senkevich TG et al. Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes. Science 1996; 273: 813-816.
19. Krathwohl MD et al. Functional characterization of the C-C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2. Proc Natl Acad Sci USA 1997; 94: 9875-9880.
20. Damon I, Murphy PM, Moss B. Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog. Proc Natl Acad Sci USA 1998; 95: 6403-6407.
21. Clark-Lewis I et al. Structure-activity relationships of chemokines. J Leuk Bio 1995; 57: 703-711.
22. Gottlieb SL, Myskowski PL. Molluscum contagiosum. Int J Dermatol 1994; 33: 453-461.
23. DeBruyne LA, Magee JC, Buelow R, Bromberg JS. Gene transfer of immunomodulatory peptides correlates with heme oxygenase-1 induction and enhanced allograft survival. Transplantation (in press).
24. Qin L et al. Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model: immunosuppression with TGF-β1 or vIL-10. Transplantation 1995; 59: 809-816.
25. Qin L et al. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J Immunol 1996; 156: 2316-2323.
26. DeBruyne LA et al. Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses. Gene Therapy 1998; 5: 1079-1087.
27. Moore KW et al. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990; 248: 1230-1234.
28. de Waal Malefyt R et al. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209-1220.
29. de Waal Malefyt R et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 915-924.
30. Enk AH, Angeloni VL, Udey MC, Katz SI. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J Immunol 1993; 151: 2390-2398.
31. Ding L et al. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993; 151: 1224-1234.
32. Willems F et al. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 1994; 24: 1007-1009.
33. Chan SY et al. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection. Transplantation 1995; 59: 1155-1161.
34. Fong AM et al. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med 1998; 188: 1413-1419.
35. Pan Y et al. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 1997; 387: 611-617.
36. 3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J Exp Med 1998; 188: 193-198.
37. Taub DD et al. β chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J Leuk Bio 1996; 59: 81-89.
38. Taub DD et al. Chemokines and T lymphocyte activation. I. β chemokines costimulate human T lymphocyte activation in vitro. J Immunol 1996; 156: 2095-2103.
39. Taub DD, Sayers T, Carter C, Ortaldo JR. α and β chemokines induce NK cell migration and enhance NK cell cytolytic activity via cellular degranulation. J Immunol 1995; 155: 3877-3888.
40. Philip R et al. Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes. Mol Cell Bio 1994; 14: 2411-2418.
41. Fulmer R, Cramer A, Liebelt A. Transplantation of cardiac tissue into the mouse ear. Am J Anat 1963; 113: 273-285.
42. Judd KP, Trentin JJ. Cardiac transplantation in mice: I. Factors influencing the take and survival of heterotopic grafts. Transplantation 1971; 11: 298-302.
43. Corry RJ, Winn HS, Russell PS. Primarily vascularized allografts of hearts in mice. Transplantation 1973; 16: 343-350.
44. Bishop DK, Orosz CG. Limiting dilution analysis for alloreactive, TCGF-secreting T cells: LDA methods that discriminate between unstimulated precursor T cells and in vivo alloactivated T cells. Transplantation 1989; 47: 671-677.
45. Orosz CG, Horstemeyer B, Zinn NE, Bishop DK. Development and evaluation of an LDA technique that can discriminate in vivo alloactivated CTL from their naive CTL precursors. Transplantation 1989; 47: 189-194.
46. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 1981; 126: 1614-1619.